Technology innovation stands to reap billions from a warming planet.
The company may have failed, but not everything it did was a bad idea.
Many countries keep their reserves a secret, meaning the price of oil is based on a huge amount of guesswork.
In the next five years, it will be too expensive to further miniaturize—but chip makers will innovate in different ways.
So long, itchy, uncomfortable plaster.
Cardiologist and genomic-medicine expert Eric Topol makes his case for a future of “medical selfies.”
Raising millions, Editas proved that investors are enthusiastic about gene editing. Now the company has to make its technology work.
Thirteen years after the human genome was sequenced, some remarkable treatments are being developed.
Herceptin, the original genetic drug, showed that not all cancers are alike.
His startup is using data to unlock the connections between DNA and illness.